Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
What Are Some Health Plan Best Practices Surrounding Oncology Therapy Coverage?
March 25th 2023In this AMCP Market Insights session, panelists discussed best practices and challenges when it comes to prescribing antibody drug conjugates, from the payer, provider, and patient perspectives, based on survey findings.
Read More
Jeffrey Casberg on Breakthrough Ophthalmic Drugs That Payers, Pharmacists Should Pay Attention to
March 25th 2023Among these treatments is an aflibercept product with improved dosing for the patient that is coming up for approval in a few months, explained Jeffrey Casberg, senior director of pharmacy at IPD Analytics.
Read More
Some challenges linking medication adherence to medical cost offsets include the potential of reverse causality, omitted variable bias, how adherence is measured between studies, and the outdated nature of some of the most-cited literature, said Ben Urick, PharmD, PhD, principal health outcomes researcher at Prime Therapeutics.
Read More
Dr Kevan Herold on Living With T1D: “There's Nothing You Do Without Thinking About It”
March 17th 2023It's harder for younger children to deal with the complexities of managing type 1 diabetes (T1D), so a delayed diagnosis even by a few years is a big deal, said Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine.
Read More
AMCP 2023 Will Cover Biosimilars, Inflation Reduction Act, and Much More, Says Kimberly Westrich
March 16th 2023Kimberly Westrich, director of value and access strategy at AmerisourceBergen, previews AMCP 2023 and her preconference session about incorporating value framework assessments into coverage and reimbursement decision-making.
Read More
Co-occurring Diabetes and Tooth Loss Linked to Worse, Faster Cognitive Decline
March 15th 2023New research suggests older adults with both diabetes and edentulism are more likely to experience worse and faster cognitive decline compared with adults without either condition and adults older in age.
Read More
High Resilience Linked to High PrEP Use Among Canadian MSM
March 4th 2023The study also showed, despite an existing association between discrimination based on sexual orientation and HIV pre-exposure prophylaxis (PrEP) use, increased resilience reduced the effects of such discrimination on PrEP use.
Read More
Limiting Teplizumab Coverage to First-Degree Relatives Is a Mistake, Says Dr Kevan Herold
March 3rd 2023Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine, talks about some insurers' requirement for patients to have a first-degree relative with type 1 diabetes to qualify for coverage of teplizumab.
Read More
Dr Lee Greenberger on Using Social Media to Grow a Leukemia and Lymphoma Registry
February 25th 2023In this interview, Lee Greenberger, PhD, chief scientific officer of the Leukemia and Lymphoma Society, discusses key takeaways from using social media to grow a leukemia and lymphoma registry.
Read More
Study Confirms Safety, Tolerability of Oral GABA for Type 1 Diabetes
February 23rd 2023A trial enrolling 97 children newly diagnosed with type 1 diabetes did not meet the primary endpoint of preservation of insulin production by beta cells, but it did show a significant decrease in fasting and clinically relevant reduced serum glucagon.
Read More
How Rising Insulin Costs Impacted Uninsured Populations
February 23rd 2023Researchers looked at trends in insulin usage and expenditure among insured and uninsured populations with diabetes, accounting for how the expansion of Medicaid under the Affordable Care Act may have affected these trends.
Read More